Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 3.946
Filtrar
1.
Sci Rep ; 14(1): 21082, 2024 09 10.
Artigo em Inglês | MEDLINE | ID: mdl-39256567

RESUMO

Porcine pasteurellosis is an infectious disease caused by Pasteurella multocida (P. multocida), which seriously endangers the healthy development of pig breeding industry. Early detection of disease transmission in animals is a crucial early warning for humans. Therefore, predicting risk areas for disease is essential for public health authorities to adopt preventive measures and control strategies against diseases. In this study, we developed a predictive model based on multi-criteria decision analysis (MCDA) and assessed risk areas for porcine pasteurellosis in the Chinese mainland. By using principal component analysis, the weights of seven spatial risk factors were determined. Fuzzy membership function was used to standardize all risk factors, and weight linear combination was used to create a risk map. The sensitivity of the risk map was analyzed by calculating the mean of absolute change rates of risk factors, as well as calculating an uncertainty map. The results showed that risk areas for porcine pasteurellosis were predicted to be locate in the south-central of the Chinese mainland, including Sichuan, Chongqing, Guangdong, and Guangxi. The maximum standard deviation of the uncertain map was less than 0.01and the ROC results showed that the prediction model has moderate predictive performance with the area under the curve (AUC) value of 0.80 (95% CI 0.75-0.84). Based on the above process, MCDA was combined with WebGIS technology to construct a system for predicting risk areas of porcine pasteurellosis. Risk factor data was directly linked to the developed model, providing decision support for disease prevention and control through monthly updates.


Assuntos
Técnicas de Apoio para a Decisão , Infecções por Pasteurella , Pasteurella multocida , Doenças dos Suínos , Animais , Suínos , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/microbiologia , Infecções por Pasteurella/prevenção & controle , Doenças dos Suínos/microbiologia , Doenças dos Suínos/prevenção & controle , Doenças dos Suínos/epidemiologia , China/epidemiologia , Fatores de Risco
2.
Vet Res ; 55(1): 104, 2024 Aug 29.
Artigo em Inglês | MEDLINE | ID: mdl-39210406

RESUMO

Meningitis induced by Pasteurella multocida has been substantially described in clinical practice in both human and veterinary medicine, but the underlying mechanisms have not been previously reported. In this study, we investigated the influence of P. multocida infection on the permeability of the blood-brain barrier (BBB) using different models. Our in vivo tests in a mouse model and in vitro tests using human brain microvascular endothelial cell (hBMEC) model showed that P. multocida infection increased murine BBB permeability in mice and hBMEC monolayer permeability. Furthermore, we observed that P. multocida infection resulted in decreased expression of tight junctions (ZO1, claudin-5, occludin) and adherens junctions (E-cadherin) between neighboring hBMECs. Subsequent experiments revealed that P. multocida infection promoted the activation of hypoxia inducible factor-1α (HIF-1α)/vascular endothelial growth factor A (VEGFA) signaling and NF-κB signaling, and suppressed the HIF-1α/VEGFA significantly remitted the decrease in ZO1/E-cadherin induced by P. multocida infection (P < 0.001). NF-κB signaling was found to contribute to the production of chemokines such as TNF-1α, IL-ß, and IL-6. Additionally, transmission electron microscopy revealed that paracellular migration might be the strategy employed by P. multocida to cross the BBB. This study provides the first evidence of the migration strategy used by P. multocida to traverse the mammalian BBB. The data presented herein will contribute to a better understanding of the pathogenesis of the zoonotic pathogen P. multocida.


Assuntos
Junções Aderentes , Barreira Hematoencefálica , Células Endoteliais , Infecções por Pasteurella , Pasteurella multocida , Junções Íntimas , Animais , Pasteurella multocida/fisiologia , Barreira Hematoencefálica/microbiologia , Camundongos , Junções Aderentes/metabolismo , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/microbiologia , Células Endoteliais/microbiologia , Células Endoteliais/fisiologia , Junções Íntimas/metabolismo , Humanos , Encéfalo/microbiologia , Encéfalo/irrigação sanguínea
3.
Sci Rep ; 14(1): 19626, 2024 08 23.
Artigo em Inglês | MEDLINE | ID: mdl-39179681

RESUMO

MicroRNAs (miRNAs) are important regulators of gene expression and are involved in bacterial pathogenesis and host-pathogen interactions. In this study, we investigated the function of miRNAs in the regulation of host responses to Pasteurella multocida infection. Using next-generation sequencing, we analyzed miRNA expression pattern and identified differentially expressed miRNAs in Pasteurella multocida-infected goat lungs. In addition, we investigated the function of differentially expressed miRNAs andtheir targeted signaling pathways in bacterial infection processes. The results showed that Pasteurella multocida infection led to 69 significantly differentially expressed miRNAs, including 28 known annotated miRNAs with miR-497-3p showing the most significant difference. Gene target prediction and functional enrichment analyses showed that the target genes were mainly involved in cell proliferation, regulation of the cellular metabolic process, positive regulation of cellular process, cellular senescence, PI3K-Akt signaling pathway, FoxO signaling pathway and infection-related pathways. In conclusion, these data provide a new perspective on the roles of miRNAs in Pasteurella multocida infection.


Assuntos
Cabras , Pulmão , MicroRNAs , Infecções por Pasteurella , Pasteurella multocida , Animais , MicroRNAs/genética , MicroRNAs/metabolismo , Pasteurella multocida/genética , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/microbiologia , Infecções por Pasteurella/genética , Pulmão/microbiologia , Pulmão/metabolismo , Pulmão/patologia , Perfilação da Expressão Gênica , Transdução de Sinais , Interações Hospedeiro-Patógeno/genética , Regulação da Expressão Gênica , Sequenciamento de Nucleotídeos em Larga Escala , Doenças das Cabras/microbiologia , Doenças das Cabras/genética , Transcriptoma
4.
Microb Pathog ; 193: 106768, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38960217

RESUMO

Fowl cholera is an infectious disease that affects both poultry and wild birds, characterized by hemorrhagic and septicemic symptoms, caused by Pasteurella multocida (P. multocida), and leading to substantial economic losses in the poultry sector. The development of genetic engineering vaccines against avian P. multocida encountered early-stage challenges due to the limited availability of effective gene editing tools. Presently, NgAgoDM-enhanced homologous recombination stands as a potent technique for achieving efficient gene knockout in avian P. multocida. Hence, this study employed NgAgoDM-enhanced homologous recombination to target and knockout hyaE (239-359aa), hyaD, hexABC, and hexD, denoted as ΔhyaE (239-359aa), ΔhyaD, ΔhexABC, and ΔhexD, respectively. Additionally, we generated a hyaD recovery strain with two point mutations, designated as mhyaD. Thus, this study systematically examined the impact of capsular synthetic gene clusters on the pathogenicity of P. multocida. Moreover, the study demonstrated the critical role of hyaD activity in the virulence of avian P. multocida. This study offers novel insights for enhancing attenuated vaccines further.


Assuntos
Infecções por Pasteurella , Pasteurella multocida , Doenças das Aves Domésticas , Pasteurella multocida/genética , Pasteurella multocida/patogenicidade , Animais , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/microbiologia , Virulência/genética , Doenças das Aves Domésticas/microbiologia , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/genética , Recombinação Homóloga , Vacinas Atenuadas/imunologia , Vacinas Atenuadas/genética , Técnicas de Inativação de Genes , Galinhas/microbiologia , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Aves/microbiologia , Família Multigênica , Fatores de Virulência/genética , Aves Domésticas/microbiologia
5.
Microb Pathog ; 194: 106799, 2024 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-39025382

RESUMO

Pasturella multocida (P. multocida), a gram-negative bacterium, has long been a focus of interest in animal health because of its capacity to cause different infections, including hemorrhagic septicemia. Yaks, primarily found in high-altitude environments, are among the several livestock animals affected by these bacteria. Yaks are essential to the socioeconomic life of the people who depend on them since they are adapted to the cold and hypoxic conditions of highland environments. Nevertheless, these terrains exhibit a greater incidence of P. multocida despite the severe environmental complications. This predominance has been linked to the possible attenuation of the yak's immunological responses in such circumstances and the evolution of some bacterial strains to favor survival in the respiratory passages of the animals. Moreover, these particular strains threaten other cattle populations that interact with yaks, which might result in unanticipated outbreaks in areas previously thought to be low risk. Considering these findings, designing and executing preventative and control strategies suited explicitly for these distinct biological environments is imperative. Through such strategies, yaks' health will be guaranteed, and a larger bovine population will be safeguarded against unanticipated epidemics. The current review provides thorough insights that were previously dispersed among several investigations. Its distinct method of connecting the ecology of yaks with the dynamics of infection offers substantial background information for further studies and livestock management plans.


Assuntos
Altitude , Doenças dos Bovinos , Gado , Infecções por Pasteurella , Pasteurella multocida , Animais , Pasteurella multocida/imunologia , Pasteurella multocida/patogenicidade , Bovinos , Doenças dos Bovinos/microbiologia , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/microbiologia , Gado/microbiologia , Surtos de Doenças , Septicemia Hemorrágica/microbiologia , Septicemia Hemorrágica/imunologia
6.
mSphere ; 9(8): e0029724, 2024 Aug 28.
Artigo em Inglês | MEDLINE | ID: mdl-39041808

RESUMO

Interaction between viruses and bacteria during the development of infectious diseases is a complex question that requires continuous study. In this study, we explored the interactions between pseudorabies virus (PRV) and Pasteurella multocida (PM), which are recognized as the primary and secondary agents of porcine respiratory disease complex (PRDC), respectively. In vivo tests using mouse models demonstrated that intranasal inoculation with PRV at a sublethal dose induced disruption of murine respiratory barrier and promoted the invasion and damages caused by PM through respiratory infection. Inoculation with PRV also disrupted the barrier function of murine and porcine respiratory epithelial cells, and accelerated the adherence and invasion of PM to the cells. In mechanism, PRV infection resulted in decreased expression of tight junction proteins (ZO-1, occludin) and adherens junction proteins (ß-catenin, E-cadherin) between neighboring respiratory epithelial cells. Additionally, PRV inoculation at an early stage downregulated multiple biological processes contributing to epithelial adhesion and barrier functions while upregulating signals beneficial for respiratory barrier disruption (e.g., the HIF-1α signaling). Furthermore, PRV infection also stimulated the upregulation of cellular receptors (CAM5, ICAM2, ACAN, and DSCAM) that promote bacterial adherence. The data presented in this study provide insights into the understanding of virus-bacteria interactions in PRDC and may also contribute to understanding the mechanisms of secondary infections caused by different respiratory viruses (e.g., influenza virus and SARS-CoV-2) in both medical and veterinary medicine. IMPORTANCE: Co-infections caused by viral and bacterial agents are common in both medical and veterinary medicine, but the related mechanisms are not fully understood. This study investigated the interactions between the zoonotic pathogens PRV and PM during the development of respiratory infections in both cell and mouse models, and reported the possible mechanisms which included: (i) the primary infection of PRV may induce the disruption and/or damage of mammal respiratory barrier, thereby contributing to the invasion of PM; (ii) PRV infection at early stage accelerates the transcription and/or expression of several cellular receptors that are beneficial for bacterial adherence. This study may shed a light on understanding the mechanisms on the secondary infection of PM promoted by different respiratory viruses (e.g., influenza virus and SARS-CoV-2) in both medical and veterinary medicine.


Assuntos
Herpesvirus Suídeo 1 , Infecções por Pasteurella , Pasteurella multocida , Pseudorraiva , Animais , Pasteurella multocida/patogenicidade , Pasteurella multocida/fisiologia , Camundongos , Infecções por Pasteurella/microbiologia , Herpesvirus Suídeo 1/fisiologia , Suínos , Pseudorraiva/virologia , Pseudorraiva/metabolismo , Coinfecção/microbiologia , Coinfecção/virologia , Células Epiteliais/virologia , Células Epiteliais/microbiologia , Permeabilidade , Feminino , Doenças dos Suínos/microbiologia , Doenças dos Suínos/virologia , Doenças dos Suínos/metabolismo , Camundongos Endogâmicos BALB C , Modelos Animais de Doenças , Mucosa Respiratória/virologia , Mucosa Respiratória/microbiologia , Mucosa Respiratória/metabolismo
7.
Front Immunol ; 15: 1392681, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38835751

RESUMO

Background: Pasteurella multocida is a bacterial pathogen that causes a variety of infections across diverse animal species, with one of the most devastating associated diseases being hemorrhagic septicemia. Outbreaks of hemorrhagic septicemia in cattle and buffaloes are marked by rapid progression and high mortality. These infections have particularly harmful socio-economic impacts on small holder farmers in Africa and Asia who are heavily reliant on a small number of animals kept as a means of subsistence for milk and draft power purposes. A novel vaccine target, PmSLP-3, has been identified on the surface of hemorrhagic septicemia-associated strains of P. multocida and was previously shown to elicit robust protection in cattle against lethal challenge with a serogroup B strain. Methods: Here, we further investigate the protective efficacy of this surface lipoprotein, including evaluating the immunogenicity and protection upon formulation with a variety of adjuvants in both mice and cattle. Results: PmSLP-3 formulated with Montanide ISA 61 elicited the highest level of serum and mucosal IgG, elicited long-lasting serum antibodies, and was fully protective against serogroup B challenge. Studies were then performed to identify the minimum number of doses required and the needed protein quantity to maintain protection. Duration studies were performed in cattle, demonstrating sustained serum IgG titres for 3 years after two doses of vaccine and full protection against lethal serogroup B challenge at 7 months after a single vaccine dose. Finally, a serogroup E challenge study was performed, demonstrating that PmSLP-3 vaccine can provide protection against challenge by the two serogroups responsible for hemorrhagic septicemia. Conclusion: Together, these data indicate that PmSLP-3 formulated with Montanide ISA 61 is an immunogenic and protective vaccine against hemorrhagic septicemia-causing P. multocida strains in cattle.


Assuntos
Anticorpos Antibacterianos , Vacinas Bacterianas , Doenças dos Bovinos , Septicemia Hemorrágica , Pasteurella multocida , Animais , Bovinos , Pasteurella multocida/imunologia , Septicemia Hemorrágica/prevenção & controle , Septicemia Hemorrágica/veterinária , Septicemia Hemorrágica/imunologia , Septicemia Hemorrágica/microbiologia , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/administração & dosagem , Doenças dos Bovinos/prevenção & controle , Doenças dos Bovinos/imunologia , Doenças dos Bovinos/microbiologia , Camundongos , Anticorpos Antibacterianos/sangue , Anticorpos Antibacterianos/imunologia , Feminino , Sorogrupo , Infecções por Pasteurella/prevenção & controle , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/imunologia , Infecções por Pasteurella/microbiologia , Adjuvantes Imunológicos/administração & dosagem , Imunoglobulina G/sangue , Imunoglobulina G/imunologia , Camundongos Endogâmicos BALB C , Vacinação
8.
Emerg Infect Dis ; 30(7): 1475-1477, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38916800

RESUMO

Pasteurella bettyae is a gram-negative bacillus sporadically involved in human infections; its main reservoirs are cats and dogs. A recent publication suggests the possibility of sexual transmission leading to genital infections in men who have sex with men. We report 9 cases in France of genital infection among this population.


Assuntos
Homossexualidade Masculina , Infecções por Pasteurella , Pasteurella , Humanos , Masculino , França/epidemiologia , Adulto , Infecções por Pasteurella/transmissão , Infecções por Pasteurella/microbiologia , Pasteurella/isolamento & purificação , Pasteurella/genética , Pasteurella/classificação , Pessoa de Meia-Idade , Adulto Jovem
9.
Acta Vet Hung ; 72(2): 71-79, 2024 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-38842941

RESUMO

The spread of antibiotic resistance is one of the biggest challenges of our time, making it difficult to treat bacterial diseases. Pasteurella multocida is a widespread facultative pathogenic bacterium, which causes a wide range of diseases in both mammals and birds. In the present study, antibiotic susceptibility of 155 P. multocida strains were tested using the broth microdilution method to obtain the minimum inhibitory concentration (MIC) values for 15 antibiotics. The most effective antibiotics against pasteurellosis were ceftiofur, tetracycline, doxycycline, florfenicol and tilmicosin. Of the strains, 12 proved to be multi-drug resistant (MDR). To combat antibiotic resistance, it is important to establish a pre-treatment antibiotic susceptibility profile. A well-chosen antibiotic would not only make the treatment more successful but may also slow down the spread of resistance and the evolution of MDR strains.


Assuntos
Anti-Infecciosos , Farmacorresistência Bacteriana , Pasteurella multocida , Pasteurella multocida/efeitos dos fármacos , Pasteurella multocida/isolamento & purificação , Anti-Infecciosos/farmacologia , Testes de Sensibilidade Microbiana , Infecções por Pasteurella/microbiologia , Farmacorresistência Bacteriana Múltipla , Aves/microbiologia , Mamíferos/microbiologia , Animais , Bovinos
10.
Virulence ; 15(1): 2359467, 2024 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38808732

RESUMO

Pasteurella multocida (P. multocida) is a bacterial pathogen responsible for a range of infections in humans and various animal hosts, causing significant economic losses in farming. Integrative and conjugative elements (ICEs) are important horizontal gene transfer elements, potentially enabling host bacteria to enhance adaptability by acquiring multiple functional genes. However, the understanding of ICEs in P. multocida and their impact on the transmission of this pathogen remains limited. In this study, 42 poultry-sourced P. multocida genomes obtained by high-throughput sequencing together with 393 publicly available P. multocida genomes were used to analyse the horizontal transfer of ICEs. Eighty-two ICEs were identified in P. multocida, including SXT/R391 and Tn916 subtypes, as well as three subtypes of ICEHin1056 family, with the latter being widely prevalent in P. multocida and carrying multiple resistance genes. The correlations between insertion sequences and resistant genes in ICEs were also identified, and some ICEs introduced the carbapenem gene blaOXA-2 and the bleomycin gene bleO to P. multocida. Phylogenetic and collinearity analyses of these bioinformatics found that ICEs in P. multocida were transmitted vertically and horizontally and have evolved with host specialization. These findings provide insight into the transmission and evolution mode of ICEs in P. multocida and highlight the importance of understanding these elements for controlling the spread of antibiotic resistance.


Assuntos
Transferência Genética Horizontal , Genoma Bacteriano , Infecções por Pasteurella , Pasteurella multocida , Filogenia , Pasteurella multocida/genética , Pasteurella multocida/classificação , Animais , Infecções por Pasteurella/microbiologia , Infecções por Pasteurella/epidemiologia , Infecções por Pasteurella/transmissão , Elementos de DNA Transponíveis , Conjugação Genética , Evolução Molecular , Aves Domésticas/microbiologia , Prevalência , Sequenciamento de Nucleotídeos em Larga Escala
11.
PLoS One ; 19(5): e0301688, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38768145

RESUMO

Swine atrophic rhinitis is a disease caused by Pasteurella multocida and Bordetella bronchiseptica that affects pigs. Inactivated vaccines containing the toxins produced by Pasteurella multocida and Bordetella bronchiseptica have been widely used for the prevention of swine atrophic rhinitis. The efficacy of a vaccine is correlated with the amount of antigen present; however, the protective toxin of P. multocida bound to aluminum hydroxide, which is used as an adjuvant, can hinder the monitoring of the antigen concentration in the vaccine. This study assessed the applicability of a dot immunoassay as an antigen quantification method using monoclonal antibodies. This quantification method was able to detect the antigen with high specificity and sensitivity even when the antigen was bound to the adjuvant, and its application to vaccine products revealed a correlation between the amount of antigen present in the vaccine and the neutralizing antibody titers induced in pigs. The antigen quantification method presented in this study is a simple and sensitive assay capable of quantifying the amount of antigen present in a vaccine that can be used as an alternative quality control measure.


Assuntos
Adjuvantes Imunológicos , Hidróxido de Alumínio , Antígenos de Bactérias , Vacinas Bacterianas , Pasteurella multocida , Rinite Atrófica , Doenças dos Suínos , Animais , Pasteurella multocida/imunologia , Suínos , Rinite Atrófica/imunologia , Rinite Atrófica/prevenção & controle , Rinite Atrófica/microbiologia , Vacinas Bacterianas/imunologia , Antígenos de Bactérias/imunologia , Doenças dos Suínos/prevenção & controle , Doenças dos Suínos/microbiologia , Doenças dos Suínos/imunologia , Bordetella bronchiseptica/imunologia , Anticorpos Antibacterianos/sangue , Anticorpos Antibacterianos/imunologia , Infecções por Pasteurella/prevenção & controle , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/imunologia , Anticorpos Neutralizantes/imunologia
12.
Vet Res Commun ; 48(4): 2227-2242, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38709372

RESUMO

Pasteurella multocida is affecting a multitude of animals and severely affects livestock production. Existing vaccines are mostly chemically inactivated and do not lead to wide protection. Irradiated vaccines are enjoying a renaissance and the concept of "replication defficient but metabolically active" vaccines was recently evaluated in several vaccine trials. P. multocida was isolated from the nasal swab, blood, and lung swab samples from infected rabbits. Gamma irradiation of P. multocida for inhibition of replication was evaluated at an optimized irradiation dose of 10 Kgy established. Four groups of rabbits were (mock) vaccinated with a commercial P. multocida vaccine and three irradiated formulations as liquid, lyophilized formulations with added Trehalose and lyophilized-Trehalose with an "activation" culturing the irradiated bacteria for 24 in broth. Evaluation of humoral immune response by ELISA showed that all three irradiated vaccines produced an effective, protective, and continued IgG serum level after vaccination and bacterial challenge. The IFN-γ expression is maintained at a normal level, within each individual group however, the lyophilized trehalose irradiated vaccine showed peak mean of IFN-γ titer at one week after booster dose (day 21) which was statistically significant. Cumulatively, the results of this study show that gamma-irradiated P. multocida vaccines are safe and protect rabbits against disease. Moreover, Rabbits' immunization with the three irradiated formulations avoided adverse side effects as compared to commercial polyvalent vaccine, the body weight gain for the irradiated vaccine groups indicates less stress compared to the commercial polyvalent vaccine.


Assuntos
Vacinas Bacterianas , Raios gama , Imunidade Humoral , Infecções por Pasteurella , Pasteurella multocida , Animais , Pasteurella multocida/imunologia , Pasteurella multocida/efeitos da radiação , Coelhos , Infecções por Pasteurella/prevenção & controle , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/imunologia , Vacinas Bacterianas/imunologia , Vacinas Bacterianas/administração & dosagem , Vacinas de Produtos Inativados/imunologia , Vacinas de Produtos Inativados/administração & dosagem
13.
Int J Mol Sci ; 25(10)2024 May 14.
Artigo em Inglês | MEDLINE | ID: mdl-38791369

RESUMO

Pasteurella multocida, a zoonotic pathogen that produces a 146-kDa modular toxin (PMT), causes progressive atrophic rhinitis with severe turbinate bone degradation in pigs. However, its mechanism of cytotoxicity remains unclear. In this study, we expressed PMT, purified it in a prokaryotic expression system, and found that it killed PK15 cells. The host factor CXCL8 was significantly upregulated among the differentially expressed genes in a transcriptome sequencing analysis and qPCR verification. We constructed a CXCL8-knockout cell line with a CRISPR/Cas9 system and found that CXCL8 knockout significantly increased resistance to PMT-induced cell apoptosis. CXCL8 knockout impaired the cleavage efficiency of apoptosis-related proteins, including Caspase3, Caspase8, and PARP1, as demonstrated with Western blot. In conclusion, these findings establish that CXCL8 facilitates PMT-induced PK15 cell death, which involves apoptotic pathways; this observation documents that CXCL8 plays a key role in PMT-induced PK15 cell death.


Assuntos
Toxinas Bacterianas , Interleucina-8 , Infecções por Pasteurella , Pasteurella multocida , Animais , Apoptose , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Toxinas Bacterianas/genética , Toxinas Bacterianas/toxicidade , Toxinas Bacterianas/metabolismo , Caspase 8/metabolismo , Caspase 8/genética , Linhagem Celular , Sistemas CRISPR-Cas , Técnicas de Inativação de Genes , Interleucina-8/metabolismo , Interleucina-8/genética , Pasteurella multocida/genética , Suínos , Infecções por Pasteurella/metabolismo , Infecções por Pasteurella/veterinária
14.
BMJ Case Rep ; 17(5)2024 May 24.
Artigo em Inglês | MEDLINE | ID: mdl-38789270

RESUMO

Pasteurella multocida is a gram-negative coccobacillus that is commonly transmitted through animal bites including cats and dogs. The degree of infection can be worrisome in the immunosuppressed population with a stark correlation in patients with cirrhosis. However, taking that population into account, only 13 cases of P. multocida bacteraemia have been recorded with the majority of those cases having cirrhotic liver disease along with multiple comorbidities. Here, we present an elderly patient with only pertinent medical history of mixed hyperlipidaemia who presents after a mechanical fall with acute renal failure and septic shock secondary to P. multocida bacteraemia.


Assuntos
Bacteriemia , Infecções por Pasteurella , Pasteurella multocida , Humanos , Infecções por Pasteurella/diagnóstico , Infecções por Pasteurella/tratamento farmacológico , Infecções por Pasteurella/microbiologia , Bacteriemia/microbiologia , Bacteriemia/diagnóstico , Bacteriemia/tratamento farmacológico , Pasteurella multocida/isolamento & purificação , Masculino , Idoso , Antibacterianos/uso terapêutico , Choque Séptico/microbiologia , Injúria Renal Aguda/etiologia , Injúria Renal Aguda/microbiologia
15.
J Comp Pathol ; 211: 17-20, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38759507

RESUMO

Reports of primary cardiovascular disease in goats are rare and most commonly include ventricular septal defect, valvular endocarditis, traumatic pericarditis, ionophore poisoning and nutritional cardiomyopathies. We now report the pathological findings in a 67 kg, 6-year-old, adult female Boer goat that presented with neurological signs (ie, head pressing, unsteadiness and paddling) and hyperthermia 2 days prior to death. Lack of therapeutic response to meloxicam and penicillin‒streptomycin and poor prognosis led to euthanasia of the animal. At necropsy, the main findings included severe aortic dissection with luminal thrombosis and stenosis, and pulmonary congestion and oedema. Histological examination of the aorta revealed severe chronic granulomatous and fibrosing dissecting aortitis with mineralization. Bacterial culture of the affected aortic segment resulted in isolation of a profuse growth of Pasteurella multocida and a moderate growth of Staphylococcus spp. Histopathological findings in the central nervous system were consistent with neurolisteriosis.


Assuntos
Dissecção Aórtica , Doenças das Cabras , Cabras , Infecções por Pasteurella , Pasteurella multocida , Infecções Estafilocócicas , Animais , Doenças das Cabras/microbiologia , Doenças das Cabras/patologia , Infecções por Pasteurella/veterinária , Feminino , Infecções Estafilocócicas/veterinária , Dissecção Aórtica/veterinária
17.
Vet Res ; 55(1): 46, 2024 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-38589976

RESUMO

Pasteurella multocida is an important zoonotic respiratory pathogen capable of infecting a diverse range of hosts, including humans, farm animals, and wild animals. However, the precise mechanisms by which P. multocida compromises the pulmonary integrity of mammals and subsequently induces systemic infection remain largely unexplored. In this study, based on mouse and rabbit models, we found that P. multocida causes not only lung damage but also bacteremia due to the loss of lung integrity. Furthermore, we demonstrated that bacteremia is an important aspect of P. multocida pathogenesis, as evidenced by the observed multiorgan damage and systemic inflammation, and ultimately found that this systemic infection leads to a cytokine storm that can be mitigated by IL-6-neutralizing antibodies. As a result, we divided the pathogenesis of P. multocida into two phases: the pulmonary infection phase and the systemic infection phase. Based on unbiased RNA-seq data, we discovered that P. multocida-induced apoptosis leads to the loss of pulmonary epithelial integrity. These findings have been validated in both TC-1 murine lung epithelial cells and the lungs of model mice. Conversely, the administration of Ac-DEVD-CHO, an apoptosis inhibitor, effectively restored pulmonary epithelial integrity, significantly mitigated lung damage, inhibited bacteremia, attenuated the cytokine storm, and reduced mortality in mouse models. At the molecular level, we demonstrated that the FAK-AKT-FOXO1 axis is involved in P. multocida-induced lung epithelial cell apoptosis in both cells and animals. Thus, our research provides crucial information with regard to the pathogenesis of P. multocida as well as potential treatment options for this and other respiratory bacterial diseases.


Assuntos
Bacteriemia , Infecções por Pasteurella , Pasteurella multocida , Doenças dos Roedores , Humanos , Animais , Coelhos , Camundongos , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/microbiologia , Proteínas Proto-Oncogênicas c-akt , Síndrome da Liberação de Citocina/patologia , Síndrome da Liberação de Citocina/veterinária , Pulmão/patologia , Bacteriemia/veterinária , Bacteriemia/patologia , Apoptose , Mamíferos , Proteína Forkhead Box O1
18.
ScientificWorldJournal ; 2024: 5605552, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38655561

RESUMO

Background: Pasteurella species are frequently encountered as serious diseases in small ruminants. It is the main cause of respiratory pasteurellosis in sheep and goats of all age groups. Methods: The cross-sectional study was conducted from December 2022 to April 2023 in Haramaya district, eastern Ethiopia, to isolate and identify Pasteurella multocida and Mannheimia haemolytica and estimate their prevalence, associated risk factors, and antimicrobial sensitivity of isolates in small ruminants using a purposive sampling method. A total of 384 samples (156 nasal swabs from clinic cases and 228 lung swabs from abattoir cases) were collected. STATA 14 software was used to analyze the data. In addition, multivariable logistic regression analysis was performed to assess an association of risk factors. Results: Out of the 384 samples examined, 164 were positive for pasteurellosis, resulting in a 42.70% prevalence. Similarly, 63 (38.4%) of the 164 positive results were from nasal swabs, while 101 (61.6%) came from lung samples. M. haemolytica accounted for 126 (76.82%) of the isolates, while P. multocida accounted for 38 (23.17%). Of the 63 nasal swab isolates, 33 (37%) were from goats and 30 (42.8%) were from sheep. And 17 (10.89%) and 46 (29.58%), respectively, were P. multocida and M. haemolytica. Of the 46 (40%) of the 101 (44.3%) isolates of the pneumonic lung, samples were from goats, while 55 (48.47%) were from sheep. In this study, the risk factors (species, age, and body condition score) were found to be significant (p < 0.05). Pasteurella isolates evaluated for antibiotic susceptibility were highly resistant to oxacillin (90.90%), followed by gentamycin (72.72%), and penicillin (63.63%). However, the isolates were highly sensitive to chloramphenicol (90.90%), followed by tetracycline (63.63%), and ampicillin (54.54%). Conclusion: This study showed that M. haemolytica and P. multocida are the common causes of mannheimiosis and pasteurellosis in small ruminants, respectively, and isolates were resistant to commonly used antibiotics in the study area. Thus, an integrated vaccination strategy, antimicrobial resistance monitoring, and avoidance of stress-inducing factors are recommended.


Assuntos
Antibacterianos , Cabras , Mannheimia haemolytica , Testes de Sensibilidade Microbiana , Pasteurella multocida , Doenças dos Ovinos , Animais , Pasteurella multocida/efeitos dos fármacos , Pasteurella multocida/isolamento & purificação , Mannheimia haemolytica/efeitos dos fármacos , Mannheimia haemolytica/isolamento & purificação , Etiópia/epidemiologia , Ovinos/microbiologia , Cabras/microbiologia , Antibacterianos/farmacologia , Estudos Transversais , Doenças dos Ovinos/microbiologia , Doenças dos Ovinos/epidemiologia , Doenças das Cabras/microbiologia , Doenças das Cabras/epidemiologia , Prevalência , Fatores de Risco , Infecções por Pasteurella/microbiologia , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/epidemiologia
19.
Vaccine ; 42(12): 3075-3083, 2024 Apr 30.
Artigo em Inglês | MEDLINE | ID: mdl-38584060

RESUMO

As the major outer membrane protein (OMP) presents in the Pasteurella multocida envelope, OmpH was frequently expressed for laboratory assessments of its immunogenicity against P. multocida infections, but the results are not good. In this study, we modified OmpH with dendritic cell targeting peptide (Depeps) and/or Salmonella FliCd flagellin, and expressed three types of recombinant proteins with the MBP tag (rDepeps-FliC-OmpH-MBP, rDepeps-OmpH-MBP, rFliC-OmpH-MBP). Assessments in mouse models revealed that vaccination with rDepeps-FliC-OmpH-MBP, rDepeps-OmpH-MBP, or rFliC-OmpH-MBP induced significant higher level of antibodies as well as IFN-γ and IL-4 in murine sera than vaccination with rOmpH-MBP (P < 0.5). Vaccination with the three modified proteins also provided increased protection (rDepeps-FliC-OmpH-MBP, 70 %; rDepeps-OmpH-MBP, 50 %; rFliC-OmpH-MBP, 60 %) against P. multocida serotype D compared to vaccination with rOmpH-MBP (30 %). In mice vaccinated with different types of modified OmpHs, a significantly decreased bacterial strains were recovered from bloods, lungs, and spleens compared to rOmpH-MBP-vaccinated mice (P < 0.5). Notably, our assessments also demonstrated that vaccination with rDepeps-FliC-OmpH-MBP provided good protection against infections caused by a heterogeneous group of P. multocida serotypes (A, B, D). Our above findings indicate that modification with DCpep and Salmonella flagellin could be used as a promising strategy to improve vaccine effectiveness.


Assuntos
Infecções por Pasteurella , Pasteurella multocida , Animais , Camundongos , Sorogrupo , Infecções por Pasteurella/prevenção & controle , Flagelina/metabolismo , Proteínas da Membrana Bacteriana Externa , Peptídeos/metabolismo , Células Dendríticas , Vacinas Bacterianas
20.
BMC Vet Res ; 20(1): 147, 2024 Apr 20.
Artigo em Inglês | MEDLINE | ID: mdl-38643185

RESUMO

BACKGROUND: Gamithromycin is an effective therapy for bovine and swine respiratory diseases but not utilized for rabbits. Given its potent activity against respiratory pathogens, we sought to determine the pharmacokinetic profiles, antimicrobial activity and target pharmacokinetic/pharmacodynamic (PK/PD) exposures associated with therapeutic effect of gamithromycin against Pasteurella multocida in rabbits. RESULTS: Gamithromycin showed favorable PK properties in rabbits, including high subcutaneous bioavailability (86.7 ± 10.7%) and low plasma protein binding (18.5-31.9%). PK analysis identified a mean plasma peak concentration (Cmax) of 1.64 ± 0.86 mg/L and terminal half-life (T1/2) of 31.5 ± 5.74 h after subcutaneous injection. For P. multocida, short post-antibiotic effects (PAE) (1.1-5.3 h) and post-antibiotic sub-inhibitory concentration effects (PA-SME) (6.6-9.1 h) were observed after exposure to gamithromycin at 1 to 4× minimal inhibitory concentration (MIC). Gamithromycin demonstrated concentration-dependent bactericidal activity and the PK/PD index area under the concentration-time curve over 24 h (AUC24h)/MIC correlated well with efficacy (R2 > 0.99). The plasma AUC24h/MIC ratios of gamithromycin associated with the bacteriostatic, bactericidal and bacterial eradication against P. multocida were 15.4, 24.9 and 27.8 h in rabbits, respectively. CONCLUSIONS: Subcutaneous administration of 6 mg/kg gamithromycin reached therapeutic concentrations in rabbit plasma against P. multocida. The PK/PD ratios determined herein in combination with ex vivo activity and favorable rabbit PK indicate that gamithromycin may be used for the treatment of rabbit pasteurellosis.


Assuntos
Doenças dos Bovinos , Lagomorpha , Infecções por Pasteurella , Pasteurella multocida , Doenças dos Suínos , Coelhos , Animais , Bovinos , Suínos , Antibacterianos/uso terapêutico , Antibacterianos/farmacocinética , Infecções por Pasteurella/tratamento farmacológico , Infecções por Pasteurella/veterinária , Infecções por Pasteurella/microbiologia , Macrolídeos/uso terapêutico , Macrolídeos/farmacocinética , Testes de Sensibilidade Microbiana/veterinária , Doenças dos Bovinos/tratamento farmacológico , Doenças dos Suínos/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA